Literature DB >> 20407818

Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996-2009.

Khader N Mustafa1, Said S Dahbour.   

Abstract

To describe demographic characteristics, clinical features and outcome of Jordanian patients with idiopathic inflammatory myopathies (IIM), a retrospective chart review of all patients diagnosed with IIM at Jordan University Hospital between 1996 and 2009 was carried out. Thirty patients with IIM were identified. Female to male ratio was 1.7:1, with mean age at diagnosis 34.3 ± 9.2 (10-72) years with bimodal presentation at 21 and 49 years and a mean follow-up of 6.5 ± 5.7 years. Eleven patients had polymyositis (PM); 19 patients had dermatomyositis (DM); 1 patient had DM with malignancy; 2 patients had juvenile DM; and 2 patients had DM/PM with other rheumatologic diseases. Raynaud's phenomenon was present in 26% of patients, dysphagia in 40%, fever in 16%, arthralgia/arthritis in 26%, and dyspnea was present in 26% patients. Positive muscle biopsy and EMG were present in 81% and 92% of patients, respectively. Elevated serum creatinine kinase (CK), AST/ALT and LDH were found in 90%, 72%, and 88% of patients at presentation, respectively. Interstitial fibrosis identified on high-resolution computed tomography (HRCT) was found in 7/14 (50%) patients. Restrictive lung disease was present in 16/21 (76%), low diffusion capacity of lung of carbon monoxide (DLCO) in 10/17 (59%) and pulmonary hypertension in only 3/19 (16%) patients tested. Arab Jordanian patients with IIM showed very low prevalence of malignancy, lower mean age than previous reports, and similar other clinical, laboratory and serologic markers, and survival rate to previous reports. Of interest, we found that extra-muscular manifestations were mainly associated with dermatomyositis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20407818     DOI: 10.1007/s10067-010-1465-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  42 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.

Authors:  I Marie; E Hachulla; P Y Hatron; M F Hellot; H Levesque; B Devulder; H Courtois
Journal:  J Rheumatol       Date:  2001-10       Impact factor: 4.666

Review 3.  Polymyositis, dermatomyositis and inclusion-body myositis.

Authors:  M C Dalakas
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

4.  Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.

Authors:  B Sigurgeirsson; B Lindelöf; O Edhag; E Allander
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

5.  Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.

Authors:  E H Kang; E B Lee; K C Shin; C H Im; D H Chung; S K Han; Y W Song
Journal:  Rheumatology (Oxford)       Date:  2005-06-21       Impact factor: 7.580

6.  Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology.

Authors:  Maryam Fathi; Jenny Vikgren; Marianne Boijsen; Ulf Tylen; Lennart Jorfeldt; Göran Tornling; Ingrid E Lundberg
Journal:  Arthritis Rheum       Date:  2008-05-15

7.  Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases.

Authors:  Katalin Dankó; Andrea Ponyi; Tamás Constantin; Gábor Borgulya; Gyula Szegedi
Journal:  Medicine (Baltimore)       Date:  2004-01       Impact factor: 1.889

8.  Pattern of adult onset of polymyositis and dermatomyositis and association with malignancy.

Authors:  S T Al-Ballaa; A N Al-Dalaan; K M El-Ramahi; M A Al-Janadi; A Al-Shaikh; S Bahabri
Journal:  Ann Saudi Med       Date:  1993-11       Impact factor: 1.526

9.  Interstitial lung disease in polymyositis and dermatomyositis.

Authors:  I Marie; E Hachulla; P Chérin; S Dominique; P-Y Hatron; M-F Hellot; B Devulder; S Herson; H Levesque; H Courtois
Journal:  Arthritis Rheum       Date:  2002-12-15

10.  Elevated cancer incidence in patients with dermatomyositis: a population based study.

Authors:  A Airio; E Pukkala; H Isomäki
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

View more
  10 in total

1.  AIIMDs: An Integrated Framework of Automatic Idiopathic Inflammatory Myopathy Diagnosis for Muscle.

Authors:  Manish Sapkota; Fujun Liu; Yuanpu Xie; Hai Su; Fuyong Xing; Lin Yang
Journal:  IEEE J Biomed Health Inform       Date:  2017-04-13       Impact factor: 5.772

2.  Pulmonary hypertension in polymyositis.

Authors:  Han Wang; Tao Liu; Ying-ying Cai; Lian Luo; Meng Wang; Mengmeng Yang; Lin Cai
Journal:  Clin Rheumatol       Date:  2015-10-14       Impact factor: 2.980

Review 3.  Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.

Authors:  Eleni Tiniakou; Andrew L Mammen
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 4.  Morbidity and mortality in adult polymyositis and dermatomyositis.

Authors:  Isabelle Marie
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

5.  Mycophenolate in idiopathic inflammatory myositis: outcome data of a large South Asian cohort.

Authors:  Aswin M Nair; John Mathew; Ruchika Goel; Pramod Chebbi; Ashish Jacob Mathew; G Arvind; Bijesh Yadav; Grace Rebekah; John A J Prakash; Debashish Danda
Journal:  Clin Rheumatol       Date:  2021-01-27       Impact factor: 2.980

6.  Autoimmune Idiopathic Inflammatory Myopathies: Pharmacological Differences and Similarities by Type of Myositis and by Sociodemographic Variables.

Authors:  Luis Fernando Valladales-Restrepo; Ana Camila Delgado-Araujo; Brayan Stiven Aristizábal-Carmona; Lina María Saldarriaga-Rivera; Jorge Enrique Machado-Alba
Journal:  Int J Rheumatol       Date:  2022-07-05

7.  Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in asian population.

Authors:  Patompong Ungprasert; Napat Leeaphorn; Nattamol Hosiriluck; Wikrom Chaiwatcharayut; Nischala Ammannagari; Donald A Raddatz
Journal:  ISRN Rheumatol       Date:  2013-02-25

8.  Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China.

Authors:  Xiao Ming Shu; Xin Lu; Yao Xie; Guo Chun Wang
Journal:  BMC Neurol       Date:  2011-11-09       Impact factor: 2.474

9.  Correlation between the frequency of Th17 cell and the expression of microRNA-206 in patients with dermatomyositis.

Authors:  Xinyi Tang; Xinyu Tian; Yue Zhang; Wei Wu; Jie Tian; Ke Rui; Jia Tong; Liwei Lu; Huaxi Xu; Shengjun Wang
Journal:  Clin Dev Immunol       Date:  2013-10-30

Review 10.  Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature.

Authors:  Sébastien Sanges; Cécile M Yelnik; Olivier Sitbon; Olivier Benveniste; Kuberaka Mariampillai; Mathilde Phillips-Houlbracq; Christophe Pison; Christophe Deligny; Jocelyn Inamo; Vincent Cottin; Luc Mouthon; David Launay; Marc Lambert; Pierre-Yves Hatron; Laurence Rottat; Marc Humbert; Eric Hachulla
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.